Matches in Wikidata for { <http://www.wikidata.org/entity/Q99530240> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q99530240 description "clinical trial" @default.
- Q99530240 description "ensayo clínico" @default.
- Q99530240 description "ensayu clínicu" @default.
- Q99530240 description "klinisch onderzoek" @default.
- Q99530240 description "клінічне випробування" @default.
- Q99530240 description "临床试验" @default.
- Q99530240 name "AGEN1884 Plus AGEN2034 Combined With Cisplatin-Gemcitabine for Muscle-Invasive Bladder Cancer" @default.
- Q99530240 name "AGEN1884 Plus AGEN2034 Combined With Cisplatin-Gemcitabine for Muscle-Invasive Bladder Cancer" @default.
- Q99530240 type Item @default.
- Q99530240 label "AGEN1884 Plus AGEN2034 Combined With Cisplatin-Gemcitabine for Muscle-Invasive Bladder Cancer" @default.
- Q99530240 label "AGEN1884 Plus AGEN2034 Combined With Cisplatin-Gemcitabine for Muscle-Invasive Bladder Cancer" @default.
- Q99530240 prefLabel "AGEN1884 Plus AGEN2034 Combined With Cisplatin-Gemcitabine for Muscle-Invasive Bladder Cancer" @default.
- Q99530240 prefLabel "AGEN1884 Plus AGEN2034 Combined With Cisplatin-Gemcitabine for Muscle-Invasive Bladder Cancer" @default.
- Q99530240 P1132 Q99530240-8633BFBD-769E-497D-8D1D-FDF295BBB33C @default.
- Q99530240 P1476 Q99530240-A095C817-33AD-46B3-A209-CCD25CD4CEA3 @default.
- Q99530240 P17 Q99530240-44DA0ADD-8CE9-41B8-8B53-736261F96810 @default.
- Q99530240 P2899 Q99530240-C2AAF066-259F-4967-8313-B3ECF6B2E273 @default.
- Q99530240 P3098 Q99530240-401AC7A1-136C-4442-98A4-1A0A7935F866 @default.
- Q99530240 P31 Q99530240-3A38B9BB-A443-4333-A9B3-635AB3432504 @default.
- Q99530240 P4844 Q99530240-63ACF74B-155D-4FB7-8944-AC9B22992301 @default.
- Q99530240 P4844 Q99530240-B3CCC527-472D-47DB-A9A5-5087AF69E8E8 @default.
- Q99530240 P580 Q99530240-5A1D6356-6A7A-4141-A022-AD14AF8E51F4 @default.
- Q99530240 P582 Q99530240-BB77A4D6-5C1C-4B87-96C9-011799619617 @default.
- Q99530240 P6099 Q99530240-37B7BD7F-0452-489D-BB40-82D36CD451F2 @default.
- Q99530240 P8005 Q99530240-C48704C5-EB99-4B60-8BBD-639ED05A6154 @default.
- Q99530240 P8363 Q99530240-8312318D-F834-403D-87EB-93F8FFF0D96B @default.
- Q99530240 P1132 "+42" @default.
- Q99530240 P1476 "A Phase II Trial of Neoadjuvant AGEN1884 Plus AGEN2034 in Combination With Cisplatin-Gemcitabine for Muscle-Invasive Bladder Cancer Prior to Radical Cystectomy" @default.
- Q99530240 P17 Q30 @default.
- Q99530240 P2899 "+18" @default.
- Q99530240 P3098 "NCT04430036" @default.
- Q99530240 P31 Q30612 @default.
- Q99530240 P4844 Q412415 @default.
- Q99530240 P4844 Q414143 @default.
- Q99530240 P580 "2020-08-01T00:00:00Z" @default.
- Q99530240 P582 "2023-07-01T00:00:00Z" @default.
- Q99530240 P6099 Q42824440 @default.
- Q99530240 P8005 Q76649614 @default.
- Q99530240 P8363 Q78089383 @default.